Advertisement
Research Article Free access | 10.1172/JCI115278
Institute of General Pathology, University of Trieste, Italy.
Find articles by Dobrina, A. in: JCI | PubMed | Google Scholar
Institute of General Pathology, University of Trieste, Italy.
Find articles by Menegazzi, R. in: JCI | PubMed | Google Scholar
Institute of General Pathology, University of Trieste, Italy.
Find articles by Carlos, T. in: JCI | PubMed | Google Scholar
Institute of General Pathology, University of Trieste, Italy.
Find articles by Nardon, E. in: JCI | PubMed | Google Scholar
Institute of General Pathology, University of Trieste, Italy.
Find articles by Cramer, R. in: JCI | PubMed | Google Scholar
Institute of General Pathology, University of Trieste, Italy.
Find articles by Zacchi, T. in: JCI | PubMed | Google Scholar
Institute of General Pathology, University of Trieste, Italy.
Find articles by Harlan, J. in: JCI | PubMed | Google Scholar
Institute of General Pathology, University of Trieste, Italy.
Find articles by Patriarca, P. in: JCI | PubMed | Google Scholar
Published July 1, 1991 - More info
We have examined the mechanisms involved in the adherence of normal peripheral blood eosinophils to cultured human umbilical vein endothelial cells (HEC) under three conditions: (a) adherence in the absence of treatment of HEC or eosinophils with activating agents (basal adherence); (b) adherence induced by stimulation of eosinophils with phorbol ester (eosinophil-dependent adherence); and (c) adherence induced by pretreatment of HEC with LPS, tumor necrosis factor (TNF), or IL-1 (endothelial-dependent adherence). A mechanism was identified that was equally active in basal, eosinophil-dependent, and endothelial-dependent adherence. This mechanism was optimally active in the presence of both Ca++ and Mg++, and reduced in the presence of Ca++ only or Mg++ only. Furthermore, like the other mechanisms of eosinophil adherence, it was active at 37 degrees C but not at 4 degrees C. A second mechanism of adherence was involved in eosinophil- and in endothelial-dependent adherence. This mechanism was dependent on the CD11/CD18 adhesion complex of eosinophils (i.e., inhibited by anti-CD18 MAb) and it was active in the presence of Ca++ and Mg++ or Mg++ only, but not Ca++ only. The third mechanism of adherence was specific for endothelial-dependent adherence. It involved the endothelial ligand vascular cell adhesion molecule-1 (VCAM-1) and the eosinophil receptor very late activation antigen-4 (VLA-4, CD49d/CD29, i.e., inhibited by anti-VCAM-1 MAb or anti-VLA-4 MAb). This mechanism was active in the presence of Ca++ and Mg++ but not of Ca++ only or Mg++ only, and was not up- or downregulated when eosinophils were stimulated with phorbol ester. In contrast, the endothelial leukocyte adhesion molecule-1 (ELAM-1), that binds neutrophils and monocytes, was not involved in eosinophil adherence to LPS-, TNF-, or IL-1-stimulated HEC (i.e., not inhibited by anti-ELAM-1 MAb). We conclude that eosinophils, like monocytes and lymphocytes, bind to the cytokine-induced endothelial ligand VCAM-1 via the integrin receptor VLA-4.